Agreement signedAgreed 16 Jul 2023
Mirum Pharmaceuticals, Inc. /
Travere Therapeutics, Inc.
Mirum Pharmaceuticals, Inc. agrees to buy Travere Therapeutics, Inc.
01 / BuyerMirum Pharmaceuticals, Inc.
02 / TargetTravere Therapeutics, Inc.
What happened
Mirum Pharmaceuticals, Inc. agreed to acquire Travere Therapeutics, Inc. for $210,000,000, according to a filing dated Sept. 5, 2023.
The source
Everything on this page comes from the source below.
01
Source · Original source
Mirum Pharmaceuticals, Inc. agrees to buy Travere Therapeutics, Inc.
This document is the source for the companies, stage and people on this page.
Original filingUnlock with ProTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Published by the source
The source this page is built from.
Announced
The source this page is built from.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request accessAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly